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Abstract 
Dendritic cell immunoreceptor (DCIR) is a C-type lectin with an immunoreceptor 
tyrosine-based inhibitory motif (ITIM). Mice lacking DCIR1 (Dcir1-/- mice) show higher 
susceptibility to chronic arthritis with increasing age, suggesting that DCIR1 is involved 
in immune modulation via its ITIM. However, the role of DCIR1 in acute immune 
responses is not clear. In this study, we explored its role in acute experimental hepatitis. 
Upon injection of D-galactosamine and lipopolysaccharide, Dcir1-/- mice showed 
decreased mortality rates and serum levels of alanine aminotransferase (ALT). In early 
onset hepatitis, serum levels of TNF-α, which primarily cause inflammation and 
hepatocyte apoptosis, were significantly lower in Dcir1-/- mice than in wild type (WT) 
mice. In the liver of Dcir1-/- mice, influx of neutrophils and other leukocytes decreased. 
Consistently, the levels of neutrophil-chemoattractant chemokine CXCL1/KC, but not 
CXCL2/MIP-2, were lower in Dcir1-/- mice than in WT mice. However, chemotaxis of 
Dcir1-/- neutrophils to CXCL1/KC appeared normal. Pervanadate treatment induced 
binding of DCIR1 and Src homology region 2 domain-containing phosphatase (SHP)-2, 
possibly leading to CXCL1/KC expression. These results suggest that DCIR1 is involved 
in exacerbation of endotoxemic hepatitis, providing a new therapeutic target for lethal 
hepatitis. 
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Introduction 
Lectin molecules on the surface of immune cells are involved in antigen and 
pathogen recognition, resulting in antigen presentation and subsequent clearance [1]. 
During antigen recognition, lectins also transduce cellular signals that induce various 
types of immune responses. For example, Dectin-1 is well known to induce reactive 
oxygen species (ROS) [2] and interleukin (IL)-1β [3] production. On the other hand, the 
C-type lectin dendritic cell-specific intercellular adhesion molecule-3-grabbing 
non-integrin (DC-SIGN) induces production of immunosuppressive IL-10 in cooperation 
with toll-like receptors (TLRs) [4].  
Dendritic cell immunoreceptor (DCIR) [5, 6], a type II C-type lectin, is homologous 
to hepatic asialoglycoprotein receptors (ASGPRs)-1 and -2, and macrophage lectins [5]. 
Human DCIR is expressed in various types of immune cells such as dendritic cells (DCs), 
macrophages, B cells, and neutrophils, but not NK, CD4 and CD8 T cells [5, 7]. In mice, 
there are four homologues (DCIR1~4) of human DCIR [7]. DCIR recognizes both 
endogenous and pathogenic ligands, e.g., mannotriose, sulfo-Lewisa, Lewisa, Lewisb and 
human immunodeficiency virus type 1 (HIV-1) gp140 glycoproteins [8]. It is suggested 
that human DCIR and mouse DCIR1 and DCIR2 have an intracellular immunoreceptor 
tyrosine-based inhibitory motif (ITIM) that can bind to Src homology region 2 
domain-containing phosphatase (SHP)-1 and -2 [9, 10] resulting in immunosuppression. 
Consistent with such a function, human DCIR downregulates cellular protein 
Ishiguro and Fukawa et.al. 
 4 
phosphorylation after B cell receptor (BCR) ligation [6], and cytokine production via 
TLR8 [11] and TLR9 [12] signaling. DCIR polymorphism has also been involved in 
susceptibility for systemic lupus erythematosus and primary Sjogren's syndrome [13] and 
in regulatory T cell induction after intravenous treatment with immunoglobulin to 
alleviate allergic airways disease [14]. Furthermore, we have reported that 
Dcir1-deficient (Dcir1-/-) mice tend to develop autoimmune enthesitis with increased 
bone/cartilage formation with age, type II collagen-induced experimental arthritis [15, 
16], and experimental autoimmune encephalomyelitis (EAE) [17]. However, Dcir1-/- 
mice showed lower susceptibility to dextran sulfate sodium (DSS)-induced colitis [18], 
and experimental cerebral malaria than wild type (WT) mice did [19]. These results 
suggest that, in different diseases, DCIR1 can have either immune suppressing or 
enhancing roles.  
In the liver, various types of stresses, such as hepatitis virus infection, chronic 
alcohol abuse, and metabolic disorders, lead to inflammation and influx of leukocytes, 
causing tissue damage [20]. In a mouse hepatitis model, administration of 
D-galactosamine (GalN) and lipopolysaccharide (LPS) causes severe inflammation and 
lethal organ failure. After injection of GalN and LPS, various types of inflammatory 
cytokines such as TNF-α and IL-6 are rapidly upregulated. TNF-α activates caspase-3, 
leading to hepatocyte apoptosis [21]. Subsequently, influx of leukocytes into the liver 
leads to further liver damage. Among the leukocytes, neutrophils are one of the major 
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effectors in hepatitis, because an inhibitor for neutrophil’s elastase is known to relieve 
liver injury in rats [22], and neutralizing antibodies (Ab) against the chemokines 
CXCL1/KC and CXCL2/MIP-2, which are chemoattractant for neutrophils, are known to 
ameliorate experimental hepatitis [23]. These chemokines are upregulated in early stages 
of hepatitis and cooperate to exacerbate liver damage. It is also reported that ROS 
produced by neutrophils directly kill hepatocytes in endotoxemic hepatitis [24]. 
In previous studies, we have analyzed the roles of DCIR1 in various disease models 
and age groups, from several days to months [15, 17, 18]. However, the roles of DCIR1 in 
acute immune response are complex. In the present study, we analyzed the susceptibility 
of Dcir1-/- mice to experimental liver injury induced by GalN and LPS in order to further 
elucidate this point. 
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Results 
Survival rate and liver damage of Dcir1-/- mice in response to lethal hepatitis 
We first analyzed the survival rate of mice upon induction of endotoxemic hepatitis 
using GalN and LPS. The results showed a higher survival rate of Dcir1-/- than WT mice 
(Fig. 1A). The levels of serum alanine aminotransferase (ALT), which indicated 
hepatocyte death, were significantly reduced in Dcir1-/- mice at 5 h after hepatitis 
induction (Fig. 1B). Macroscopic appearance of the liver also showed less damage in 
Dcir1-/- mice than in WT mice (Fig. 1C). Liver histological analysis showed less 
destruction of hepatic structure with hemorrhage and formation of vacuoles in Dcir1-/- 
mice than in WT mice (Fig. 1D).   
The proinflammatory cytokine TNF-α primarily leads to the activation of caspase-3 
and hepatocyte apoptosis directly at the onset of hepatitis caused by GalN and LPS [21]. 
In Dcir1-/- mice, serum levels of TNF-α and other cytokines, such as IL-6, IL-10, and 
monocyte-attractive chemokine CCL1/MCP-1, were also lower than those in WT mice 
(Fig. 2), suggesting lower responsiveness to GalN and LPS.  
 
Influx of lymphocytes into the liver of Dcir1-/- mice during hepatitis 
We next checked the cell numbers and populations of leukocytes in the liver of 
Dcir1-/- mice. At steady state, the numbers of CD4+ T cells, CD8+ T cells, B cells, 
neutrophils, and monocytes in the liver of Dcir1-/- mice appeared normal (Fig. 3A). Five 
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hours after hepatitis induction, the number of total leukocytes in the livers of WT mice 
increased approximately 100 fold from that in the steady state (Fig. 3B, top panel). 
However, the increase in Dcir1-/- mice was significantly less than that in the livers of WT 
mice. Similarly, the numbers of CD4+ T cells, CD8+ T cells, B cells, and neutrophils were 
lower in the livers of Dcir1-/- mice than in that of WT mice (Fig. 3B, lower panels), being 
consistent with the liver damage in Dcir1-/- mice. 
 
Serum levels of chemokine CXCL1/KC in Dcir1-/- mice during hepatitis 
Neutrophils are thought to be major initiators and effector cells in several hepatic 
injury models using concanavalin A (Con A) [25], GalN and LPS [26], and 
ischemia/reperfusion [27]. Therefore, we focused on the neutrophil chemokines 
CXCL1/KC and CXCL2/MIP-2, which are involved in endotoxemic liver injury in mice 
[23], and we found that the serum levels of CXCL1/KC were significantly lower in 
Dcir1-/- mice than in WT mice (Fig. 4). However, the serum levels CXCL2/MIP-2 were 
identical in both mice types.  
Since neutrophils express DCIR1 [7], it is possible that the lack of DCIR1 affects 
their chemotactic response to CXCL1/KC. However, Dcir1-/- and WT neutrophils showed 
comparable chemotactic responses to CXCL1/KC (Fig. 5). We previously reported that 
responsiveness of Dcir1-/- neutrophils to CXCL2/MIP-2 was also normal [18]. This 
observation suggests that the low levels of CXCL1/KC expression in the liver of Dcir1-/- 
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mice result in decreased neutrophil influx into the liver and ameliorate liver damage. 
Taken together, our results suggest that DCIR1 upregulates CXCL1/KC production and 
subsequent influx of neutrophils, resulting in high mortality rate in endotoxemic 
hepatitis.  
 
Interaction of DCIR1 and SHP-2 
Richard et.al. reported that a phosphorylated synthetic peptide containing human 
DCIR ITIM could bind SHP-2 [10]. It was recently reported that SHP-2 induced human 
CXCL8/IL-8, a homolog of mouse CXCL1/KC and CXCL2/MIP-2, through p38 MAPK 
in astrocytes [28], and, in mice, the p38 MAPK inhibitor (SB 239063) suppresses 
induction of CXCL1/KC and CXCL2/MIP-2 during endotoxemic liver injury in vivo [29]. 
These results suggest that the DCIR1-SHP-2 pathway controls CXCL1/KC expression. 
However, binding of DCIR1 and SHP-2 has not been shown. Using HEK293T expressing 
tagged-DCIR1, we found that pervanadate treatment or antibody cross-linking led to 
DCIR1 phosphorylation (Fig. 6A and B). Such phosphorylation by pervanadate treatment 
was not observed with C-type lectin SIGNR3 containing hemi-immunoreceptor 
tyrosine-based activation motif (hemITAM) [30]. Furthermore, pervanadate treatment of 
HEK293T expressing tagged-DCIR1 induced binding of DCIR1 and SHP-2 (Fig. 6C). 
These results suggest that ligand-bound DCIR1 interacts with SHP-2 and subsequently 
enhances CXCL1/KC production. 
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Discussion 
Recently, studies aim at exploring new roles of C-type lectins in addition to their 
known functions in immune responses to pathogens. In this study, we found that DCIR1 
increased TNF-α production at the onset of endotoxemic hepatitis, and subsequent 
neutrophil influx to the liver, leading to exacerbation of liver damage and lethality. 
One of the mechanisms by which neutrophils induce hepatocyte death involves ROS 
[24, 31]. Batra et.al. reported that CXCL1/KC was essential for NADPH 
oxidase-mediated ROS production of neutrophils in polymicrobial sepsis [32]. We have 
also reported that lack of DCIR1 in neutrophils decreased ROS production in response to 
LPS in vitro [18]. Therefore, DCIR1 possibly controls not only the influx of neutrophils, 
but also their cytotoxicity via ROS production in the liver. Furthermore, CXCL1/KC is 
involved in neutrophil migration, cytokine production, NF-κB and MAPKs activation, 
and ICAM-1 expression [32]. Therefore, low induction of CXCL1/KC in Dcir1-/- mice 
may be involved in hepatitis amelioration at various steps of the immune response. 
We have studied the roles of DCIR1 during aging and in several disease models. 
Among these, DCIR1 is involved in the suppression of autoimmune enthesitis with 
increasing age [15, 16] and EAE [17]. However, in DSS-induced colitis [18] and 
endotoxemic hepatitis (present study), DCIR1 exacerbated the symptoms. In the 
autoimmune enthesitis and EAE models, the main effector cells are T cells [16, 33], 
suggesting the intervention of antigen specific immune responses. We have reported that 
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lack of DCIR1 enhanced GM-CSF signaling, resulting in an increase of DCs [15] that 
effectively induced antigen specific IFN-γ-producing T cells [16]. On the other hand, 
acute organ destruction by neutrophils occurs in DSS-induced colitis and in the 
endotoxemic hepatitis model. Downregulation of CXCL chemokines in Dcir1-/- mice 
suppresses neutrophil influx into the organs and cytotoxicity via ROS production. Taken 
together, these results suggest that DCIR1 enhances the influx of leukocytes and 
inflammation by upregulating chemokine production in an acute immune response, as 
well as suppresses excess inflammation by reducing T cell effector function via control of 
the number of DCs in a long-term immune response, resulting in dual pro- and 
anti-inflammatory roles. Therefore, the discrepancy between immune suppressive and 
enhancing functions of DCIR1 in the different disease models may be related to the 
different stages of immune response in each model. 
We have reported that, in the DSS-induced colitis model, expression of 
CXCL2/MIP-2 in the large intestine was downregulated in Dcir1-/- mice, leading to 
neutrophil influx decrease [18]. In Mφ, expression of CXCL1/KC and CXCL2/MIP-2 
were differently controlled by the Myd88-NF-κB and combined Myd88-NF-κB and 
TRIF-IRF pathways, respectively [34]. Cxcl1/Kc contains three NF-κB binding sites in 
its promoter region, whereas Cxcl2/Mip-2 contains a typical IRF and two NF-κB binding 
sites. Activation of these pathways depends on a combination of TLRs and their ligands. 
It is therefore possible that in each disease model a different combination of TLRs and 
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their ligands is involved, explaining the discrepancies we observed with respect to the 
chemokines affected in Dcir1-/- mice. Indeed, in the case of the GalN and LPS hepatitis 
model, NF-κB activity appears to be controlled by both the TLR4 and DCIR1-SHP-2 
pathways. Lack of SHP-2 decreases p65-NF-κB signaling in Mφ [35]. Therefore, NF-κB 
signaling though DCIR1-SHP-2 pathway may decrease in Dcir1-/- mice, leading to low 
expression of CXCL1/KC in hepatitis. On the other hand, attenuated NF-κB signaling 
and/or TRIF-IRF signaling may be sufficient for CXCL2/MIP-2 expression, as described 
previously [34]. The attenuation of NF-κB signaling may be responsible for the low 
levels of serum TNF-α at the onset of hepatitis. 
DCIR1 is expressed in macrophages and DCs [5]. We checked CXCL1/KC 
production in Kupffer cells and DCs purified from the liver of Dcir1-/- mice upon 
stimulation with LPS in vitro. However, the lack of DCIR1 did not decrease CXCL1/KC 
production under these conditions (Supporting Information Fig. S1). This was also the 
case in bone marrow-derived DCs. It is possible that the lack of DCIR1 indirectly affects 
CXCL1/KC production in these cell types in vivo. However, DCIR1 may require 
interactions with certain endogenous ligands [8] to augment CXCL1/KC production in 
hepatitis, as shown in Fig. 6. 
Recently, Greco et al. reported that the C-type lectin Mincle exacerbated Con 
A-induced hepatitis [36]. This result is consistent with previous data showing that Mincle 
binds with FcRγ adopter molecules at an intracellular immunoreceptor tyrosine-based 
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activation motif (ITAM), leading to NF-κB activation and inflammation via the 
Syk-CARD9/BCL10/MALT1 pathway [4]. In this report, mRNA expression of 
CXCL2/MIP-2 decreased in Mincle-/- mice, possibly indicating the involvement of 
neutrophil chemokines in this hepatitis model. CXCR1/KC, CXCR2/MIP-2, and their 
human homologue CXCL8/IL-8 are involved in various types of acute liver damage, e.g., 
alcohol injury, acetaminophen injury, ischemia reperfusion injury after transplantation, 
and Con A injury [37]. However, in the Con A-induced hepatitis model, which is 
primarily driven by T cells, the susceptibility of Dcir1-/- mice was not significantly 
different from that of WT mice in a comparison of serum ALT levels (data not shown). 
Therefore, the DCIR1-CXCL1/KC axis may play different roles in these hepatitis 
models. 
At present, the identity of the cell types susceptible to DCIR1 absence in vivo, as well 
as the signaling pathway from DCIR1 to CXCL1/KC expression are not clear. 
Nevertheless, our data indicate that DCIR1 with ITIM enhances certain immune 
responses in vivo. DCIR1 is a new therapeutic target for lethal hepatitis. Therefore, the 
signaling pathway from DCIR1 to CXCL1/KC expression should be examined in future 
experiments. In mice, DCIR2 is closely related to DCIR1 and contains ITIM [7]. 
Therefore, DCIR2 may also be involved in the exacerbation of hepatitis. 
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Materials and Methods 
Mice  
Dcir1+/- mice were generated using E14.1 embryonic stem cells, and backcrossed to 
C57BL/6J over 8 times [15]. Dcir1+/- mice were maintained under specific pathogen-free 
conditions. Control WT mice were sibling littermates co-housed with Dcir1-/- mice. Male 
mice were used at 7-9 weeks of age. All experiments were conducted according to our 
institutional guidelines. 
 
Reagents and antibodies 
FITC-conjugated anti-Gr-1 (clone RB6-8C5) was obtained from BioLegend (San 
Diego, CA). FITC-conjugated anti-CD4 (clone GK1.5) and APC-conjugated anti-CD11b 
(clone M1/70) were obtained from eBioscience (San Diego, CA). FITC-conjugated 
anti-B220 (clone RA3-6B2), anti-Ly6G (clone 1A8), PE-conjugated anti-CD3ε (clone 
145-2C11), and APC-conjugated anti-CD8 (clone 53-6.7) were obtained from BD 
Pharmingen (San Diego, CA). Biotin-conjugated F4/80 (clone BM8) was obtained from 
BioLegend. For removing dead cells in flow cytometry, 7-AAD (7-amino-actinomycin) 
(Invitrogen, Carlsbad, CA) was used. GalN and LPS (Escherichia coli 0111:B4) were 
obtained from Sigma-Aldrich (St. Louis, MO). Recombinant mouse CXCL1/KC and 
CXCL2/MIP-2 was obtained from R&D Systems (Minneapolis, MN).  
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Induction of hepatitis  
Mice were injected i.p. with PBS (200 µl/20 g mouse weight) containing 100 mg/ml 
GalN and 40 ng/ml LPS.  
 
Analysis of cytokine production 
The levels of MIP-2 were assessed by ELISA using an anti-mouse MIP-2 mAb 
(clone MAB452) and a biotin-conjugated rabbit polyclonal anti-mouse MIP-2 (R&D 
Systems) as capturing and detection Abs, respectively. The levels of KC were assessed 
with the Cytometric Bead Array (CBA) mouse KC flex set (BD Biosciences, Franklin 
Lakes, NJ). The levels of the rest of the cytokines investigated in this study were assessed 
with the CBA mouse inflammatory kit and mouse Flex sets (BD Biosciences). 
 
Chemotaxis assay 
Responsiveness of neutrophils to CXCL1/KC was evaluated by the Transwell 
chemotaxis assay. Bone marrow cells (1 × 106 cells) stained with FITC-anti-Ly6G and 
ACP-anti-CD11b mAb in 100 µl RPMI 1640 supplemented with 1% BSA and 1% 
HEPES were placed in a 3-µm pore size polycarbonate Transwell culture insert (Corning 
Costar, Tewksbury, MA). CXCL1/KC (10 ng/ml) was added at the bottom chamber. After 
1 h in a 5% CO2 environment at 37 °C, migrating cells were recovered in the bottom 
compartment and analyzed by flow cytometry. 
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Analysis of alanine aminotransferase (ALT) in serum  
Serum ALT levels were measured using Auto Sera S ALT (Sekisui Medical, Tokyo, 
Japan) in accordance with the manufacturer’s protocol. 
 
Histopathological analysis 
Tissues were fixed in Bouin's fluid and embedded in paraffin, and 4-µm sections 
were used for histopathological examinations. Sections were stained with 
hematoxylin-eosin and observed using a BZ-8000 Biozero imaging device (Keyence, 
Osaka, Japan). Images were processed with Adobe Photoshop CS6 (Adobe Systems, San 
Jose, CA). 
 
Cell preparation and stimulation to analyze cytokine production  
After systemic perfusion with PBS containing 5 mM EDTA and 100 U/ml heparin 
(Wako, Osaka, Japan), the liver was digested in 400 U/ml collagenase D (Roche Applied 
Science, Hague Road, IN) with 5,000 U/ml DNase I (Sigma-Aldrich) for 45 min at 37 °C. 
For neutrophil fractions, the single cells were suspended in 30% Percoll solution (GE 
Healthcare Life Sciences, Uppsala, Sweden) and centrifuged at 600 × g for 15 min at 
24 °C. The cell pellets were treated with ACK lysis buffer (150 mM NH4Cl, 1 mM 
KHCO3, and 0.001 mM EDTA) before flow cytometry. For the other leukocytes, single 
Ishiguro and Fukawa et.al. 
 16 
cell suspensions were prepared in 40% Percoll solution, overlaid onto 70% Percoll 
solution, and centrifuged at 1300 × g for 10 min at room temperature. Cells at the 
interface were obtained and subjected to flow cytometry using a FACSCalibur system 
(BD Biosciences). 
For Kupffer cells, single cell suspensions were prepared in 22.5% Percoll solution, 
overlaid onto 45% Percoll solution, and centrifuged at 1300 × g for 20 min. From the cells 
at the interphase, Kupffer cells were isolated using biotin-anti-F4/80 mAb and 
avidin-magnetic beads (Miltenyi Biotech, Bergisch Gladbach, Germany) in accordance 
with the manufacturer’s protocol. For liver DCs, single cell suspensions were prepared in 
36% Percoll solution, overlaid onto 54% Percoll solution, and centrifuged at 3000 × g for 
20 min. From the cells at the interphase, DCs were isolated using anti-CD11c-magnetic 
beads (Miltenyi Biotech). Bone marrow-derived DCs (BMDCs) were prepared as 
previously described [2]. BMDCs were obtained using anti-CD11c-magnetic beads. For 
cytokine production analysis, cells (2 × 104 cells) in a U bottom well were stimulated with 
50 ng/ml LPS for 24 h in RPMI1640 containing 10% FCS, and 50 µM 
β-mercaptoethanol. 
 
Construction of expression plasmids  
cDNA fragments of the Dcir1 were amplified by PCR using the forward primer 
5′-GATCGAATTCATGGCTTCAGAAATCACTTATGCAG-3′, the  
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reverse primer: 5′-GATCGCGGCCGCTAAGTTTATTTTCTTCATCTGACAAAC-3′ 
and the Phusion High-Fidelity PCR Kit (NEB, County Road, MA), and cloned between 
the Eco RI and Not I sites of pEF6/V5-His (Invitrogen), resulting in C-terminal 
V5-tagged DCIR1. The plasmid for C-terminal V5-tagged SIGNR3 has been described 
previously [38]. 
 
Immunoprecipitation and western blotting 
HEK293T cells were maintained in Dulbecco's modified Eagle medium containing 
10% FCS and 50 µM β-mercaptoethanol. The cells were transiently transfected with 
plasmid DNA using Lipofectamine 2000 (Invitrogen) in accordance with the 
manufacturer’s protocol. The following antibodies were used for immunoprecipitation 
and western blot analysis: anti-V5 (Invitrogen), anti-phosphotyrosine (PY99) (Santa 
Cruz, Finnell Street, TX) and anti-SHP-2 (C-18) (Santa Cruz). Transfected cells (1 × 106 
cells) were treated with pervanadate (0.03% H2O2, 100 µM Na3VO4), anti-V5 (10 µg/mL) 
and Na3VO4, or control mouse IgG and Na3VO4 for 10 min at 37 °C. The 
immunoprecipitation and western blot procedures were performed as previously 
described [39].  
 
Statistical analysis 
Statistical significance was determined using the two-tailed Student’s t-test. 
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Differences in the survival rate of each group were determined by the Wilcoxon test. All 
experiments were repeated at least two times and representative results are shown.  
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Figure legends 
Figure 1. Susceptibility of Dcir1-/- and WT mice to acute hepatitis.  
(A) Male Dcir1-/- (n = 8) and WT (n = 8) mice received i.v. GalN and LPS injections. The 
survival rate of mice was monitored for 24 h. * p < 0.05; Wilcoxon test. Data are 
representative of two independent experiments. (B) Serum ALT levels were analyzed 5 h 
after GalN and LPS injection (n = 4). Data are representative of two independent 
experiments. Data are shown as mean ± SD. ** p < 0.01; two-tailed Student’s t-test. (C) 
The macroscopic appearance of livers from WT and Dcir1-/- mice was compared after 5 h 
of GalN and LPS injection. (D) Liver sections before (left panels) and 5 h after (middle 
and right panels) GalN and LPS injection were compared (100× magnification). The parts 
of the middle panels enclosed in rectangles are shown in the right panels at higher 
magnification (400×). (C and D) Representative images from more than three 
experiments are shown. 
 
Figure 2. Levels of serum cytokines in Dcir1-/- and WT mice upon injection of GalN and 
LPS. Serum cytokines of Dcir1-/- and WT mice with hepatitis were analyzed at various 
time points using CBA (n = 3). Data are shown as mean ± SD and are representative of 
two independent experiments. ** p < 0.01; two-tailed Student’s t-test.  
 
Figure 3. Leucocytes in the liver of Dcir1-/- and WT mice before and after hepatitis 
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induction. (A and B) Numbers of total cells and leucocytes in liver of DCIR1-/- and WT 
mice were analyzed before (A), and after (B) 5 h of hepatitis induction. Bar graphs 
indicate cell numbers gated in the dot blots. Data are shown as mean ± SD (n = 3) and are 
representative of two independent experiments. *p < 0.05, **p < 0.01 and NS= no 
significance; two-tailed Student’s t-test.  
 
Figure 4. Levels of serum CXCL1/KC and CXCL2/MIP-2 of Dcir1-/- and WT mice upon 
hepatitis induction. 
Serum CXCL1/KC (left) and CXCL2/MIP-2 (right) levels were measured after hepatitis 
induction using CBA and ELISA, respectively. Data are shown as mean ± SD (n = 6) and 
are representative of two independent experiments. *p < 0.05; two-tailed Student’s t-test.  
 
Figure 5. Responsiveness of neutrophils of Dcir1-/- and WT mice to CXCL1/KC. (A and 
B) After staining with FITC-anti-Ly6G and ACP-anti-CD11b mAb, bone marrow cells 
were subjected to chemotaxis analyses in the presence of CXCL1/KC using a Transwell 
assay. After 1 h, cells that had migrated into the bottom well were analyzed by (A) flow 
cytometry and (B) the rate of neutrophil migration was calculated. Data are shown as 
mean ± SD (n = 3). Representative results from two independent experiments are shown. 
 
Figure 6. Phosphorylation of DCIR1 and interaction with SHP-2.  
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(A) HEK293T cells transfected with a plasmid encoding V5-tagged DCIR1, -SIGNR3 or 
a control vector, were treated with pervanadate (H2O2 and Na3VO4), and tyrosine 
phosphorylation was analyzed by anti-phosphotyrosine Ab after immunoprecipitation 
with an anti-V5 antibody (upper panel). After stripping, the blot was re-probed with 
anti-V5 mAb (lower panel). (B) HEK293T cells expressing V5-tagged DCIR1 were 
cross-linked with a control or an anti-V5 mAb in the presence of Na3VO4. After 
immunoprecipitation with an anti-V5 antibody, phosphorylation of DCIR1 was analyzed 
using an anti-phosphotyrosine Ab (upper panel). After stripping, the blot was re-probed 
with anti-V5 mAb (lower panel). (C) HEK293T cells transfected with DCIR1 were 
treated with pervanadate as described in (A) and were subjected to immunoprecipitation 
with an anti-SHP2 Ab. Binding of SHP-2 to DCIR1 was detected using an anti-V5 
antibody (upper panel). After stripping, the blot was re-probed with anti-SHP-2 mAb 
(lower panel). (A-C) Blots are representative of two independent experiments. 
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